mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.3 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |